Lipid-Modifying Agents, From Statins to PCSK9 Inhibitors: JACC Focus Seminar.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2019.11.072
Abstract: Mendelian randomization studies and randomized trials have conclusively demonstrated that lower low-density lipoprotein (LDL) cholesterol results in fewer cardiovascular events. This review describes key stages in the evolution of LDL cholesterol-lowering treatment. Data from over… read more here.
Keywords: pcsk9 inhibitors; ldl cholesterol; lipid modifying; modifying agents ... See more keywords